Answers are grounded in this paper and cite their sources.
Multicenter study shows the role of post-translational modifications in pancreatic cancer, suggesting implications for patient outcomes.
Supplementary Figure S1. The expression of five protein post-translational modifications in pancreatic tissue of patients with DFS <3 months and DFS >24 months. The representative expression picture and their quantitative results of pan-crotonylation (A), pan-phosphorylation (B), pan-methylation (C), pan-ubiquitination (D), and pan-acetylation (E) in pancreatic tissue of patients with DFS <3 months and DFS >24 months. *P < 0.05, ns: nonsignificant.
No takes yet. Share an insight, caveat, or question.
Cao et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: